Search

Amy E. Juedes

Examiner (ID: 8010, Phone: (571)272-4471 , Office: P/1644 )

Most Active Art Unit
1644
Art Unit(s)
1644
Total Applications
1273
Issued Applications
443
Pending Applications
154
Abandoned Applications
706

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6095323 [patent_doc_number] => 20110002930 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-06 [patent_title] => 'Activated T Cells' [patent_app_type] => utility [patent_app_number] => 12/746581 [patent_app_country] => US [patent_app_date] => 2008-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 17094 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20110002930.pdf [firstpage_image] =>[orig_patent_app_number] => 12746581 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/746581
Activated T Cells Dec 7, 2008 Abandoned
Array ( [id] => 5574956 [patent_doc_number] => 20090142317 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-04 [patent_title] => 'PROCESS FOR REDUCING EFFECTS OF GRAFT VERSUS HOST DISEASE USING EX VIVO EXPANDED CD4+CD25+ REGULATORY T CELLS' [patent_app_type] => utility [patent_app_number] => 12/325464 [patent_app_country] => US [patent_app_date] => 2008-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 3034 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20090142317.pdf [firstpage_image] =>[orig_patent_app_number] => 12325464 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/325464
PROCESS FOR REDUCING EFFECTS OF GRAFT VERSUS HOST DISEASE USING EX VIVO EXPANDED CD4+CD25+ REGULATORY T CELLS Nov 30, 2008 Abandoned
Array ( [id] => 6550811 [patent_doc_number] => 20100233197 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-16 [patent_title] => 'METHOD FOR GENERATING TOLEROGENIC DENDRITIC CELLS EMPLOYING DECREASED TEMPERATURE' [patent_app_type] => utility [patent_app_number] => 12/741795 [patent_app_country] => US [patent_app_date] => 2008-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9348 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20100233197.pdf [firstpage_image] =>[orig_patent_app_number] => 12741795 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/741795
METHOD FOR GENERATING TOLEROGENIC DENDRITIC CELLS EMPLOYING DECREASED TEMPERATURE Nov 12, 2008 Abandoned
Array ( [id] => 6434409 [patent_doc_number] => 20100278873 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-04 [patent_title] => 'STIMULATION OF ANTI-TUMOR IMMUNITY USING DENDRITIC CELL/TUMOR CELL FUSIONS AND ANTI-CD3/CD28' [patent_app_type] => utility [patent_app_number] => 12/741472 [patent_app_country] => US [patent_app_date] => 2008-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 27760 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0278/20100278873.pdf [firstpage_image] =>[orig_patent_app_number] => 12741472 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/741472
STIMULATION OF ANTI-TUMOR IMMUNITY USING DENDRITIC CELL/TUMOR CELL FUSIONS AND ANTI-CD3/CD28 Nov 6, 2008 Abandoned
Array ( [id] => 8328225 [patent_doc_number] => 08236318 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-08-07 [patent_title] => 'Antibodies that bind human dendritic and epithelial cell 205 (DEC-205)' [patent_app_type] => utility [patent_app_number] => 12/266745 [patent_app_country] => US [patent_app_date] => 2008-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 28741 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 255 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12266745 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/266745
Antibodies that bind human dendritic and epithelial cell 205 (DEC-205) Nov 6, 2008 Issued
Array ( [id] => 5563594 [patent_doc_number] => 20090136446 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-28 [patent_title] => 'INDUCTION OF REGULATORY T CELL-RESISTANT HELPER CD4+ T CELLS' [patent_app_type] => utility [patent_app_number] => 12/262831 [patent_app_country] => US [patent_app_date] => 2008-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 19993 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20090136446.pdf [firstpage_image] =>[orig_patent_app_number] => 12262831 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/262831
INDUCTION OF REGULATORY T CELL-RESISTANT HELPER CD4+ T CELLS Oct 30, 2008 Abandoned
Array ( [id] => 5322956 [patent_doc_number] => 20090060946 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-05 [patent_title] => 'Activation of antigen-specific T cells by virus/antigen-treated dendritic cells' [patent_app_type] => utility [patent_app_number] => 12/288553 [patent_app_country] => US [patent_app_date] => 2008-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7240 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0060/20090060946.pdf [firstpage_image] =>[orig_patent_app_number] => 12288553 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/288553
Activation of antigen-specific T cells by virus/antigen-treated dendritic cells Oct 20, 2008 Abandoned
Array ( [id] => 5993044 [patent_doc_number] => 20110014697 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-20 [patent_title] => 'Method and Kit for Rapid Isolation of Human Foxp3+ Treg Cells' [patent_app_type] => utility [patent_app_number] => 12/682674 [patent_app_country] => US [patent_app_date] => 2008-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10637 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20110014697.pdf [firstpage_image] =>[orig_patent_app_number] => 12682674 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/682674
Method and Kit for Rapid Isolation of Human Foxp3+ Treg Cells Oct 9, 2008 Abandoned
Array ( [id] => 6273135 [patent_doc_number] => 20100255507 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-07 [patent_title] => 'ANTIBODIES AND OTHER LIGANDS DIRECTED AGAINST KIR2DL4 RECEPTOR FOR PRODUCTION OF INTERFERON GAMMA' [patent_app_type] => utility [patent_app_number] => 12/249703 [patent_app_country] => US [patent_app_date] => 2008-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 14245 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0255/20100255507.pdf [firstpage_image] =>[orig_patent_app_number] => 12249703 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/249703
ANTIBODIES AND OTHER LIGANDS DIRECTED AGAINST KIR2DL4 RECEPTOR FOR PRODUCTION OF INTERFERON GAMMA Oct 9, 2008 Abandoned
Array ( [id] => 5271564 [patent_doc_number] => 20090075340 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'Kir-Binding Agents and Methods of Use Thereof' [patent_app_type] => utility [patent_app_number] => 12/244101 [patent_app_country] => US [patent_app_date] => 2008-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 35193 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20090075340.pdf [firstpage_image] =>[orig_patent_app_number] => 12244101 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/244101
KIR-binding agents and methods of use thereof Oct 1, 2008 Issued
Array ( [id] => 5984596 [patent_doc_number] => 20110097334 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-28 [patent_title] => 'Novel Marker Genes for Regulatory T Cells from Human Blood' [patent_app_type] => utility [patent_app_number] => 12/681263 [patent_app_country] => US [patent_app_date] => 2008-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 50259 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0097/20110097334.pdf [firstpage_image] =>[orig_patent_app_number] => 12681263 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/681263
Marker genes for regulatory T cells from human blood Oct 1, 2008 Issued
Array ( [id] => 7774772 [patent_doc_number] => 08119775 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-02-21 [patent_title] => 'Human anti-KIR antibodies' [patent_app_type] => utility [patent_app_number] => 12/244170 [patent_app_country] => US [patent_app_date] => 2008-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 48846 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 163 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/119/08119775.pdf [firstpage_image] =>[orig_patent_app_number] => 12244170 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/244170
Human anti-KIR antibodies Oct 1, 2008 Issued
Array ( [id] => 6228803 [patent_doc_number] => 20100183541 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'Methods of Treating Autoimmune Diseases' [patent_app_type] => utility [patent_app_number] => 12/241345 [patent_app_country] => US [patent_app_date] => 2008-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 9626 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20100183541.pdf [firstpage_image] =>[orig_patent_app_number] => 12241345 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/241345
Methods of Treating Autoimmune Diseases Sep 29, 2008 Abandoned
Array ( [id] => 9059702 [patent_doc_number] => 08546137 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-01 [patent_title] => 'Inhibition of dendritic cell-driven regulatory T cell activation and potentiation of tumor antigen-specific T cell responses by interleukin-15 and MAP kinase inhibitor' [patent_app_type] => utility [patent_app_number] => 12/286122 [patent_app_country] => US [patent_app_date] => 2008-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11430 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12286122 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/286122
Inhibition of dendritic cell-driven regulatory T cell activation and potentiation of tumor antigen-specific T cell responses by interleukin-15 and MAP kinase inhibitor Sep 26, 2008 Issued
Array ( [id] => 6392484 [patent_doc_number] => 20100303868 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-02 [patent_title] => 'EX VIVO, FAST AND EFFICIENT PROCESS TO OBTAIN ACTIVATED ANTIGEN-PRESENTING CELLS THAT ARE USEFUL FOR THERAPIES AGAINST CANCER AND IMMUNE SYSTEM-RELATED DISEASES' [patent_app_type] => utility [patent_app_number] => 12/680709 [patent_app_country] => US [patent_app_date] => 2008-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 6680 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0303/20100303868.pdf [firstpage_image] =>[orig_patent_app_number] => 12680709 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/680709
EX VIVO, FAST AND EFFICIENT PROCESS TO OBTAIN ACTIVATED ANTIGEN-PRESENTING CELLS THAT ARE USEFUL FOR THERAPIES AGAINST CANCER AND IMMUNE SYSTEM-RELATED DISEASES Sep 25, 2008 Abandoned
Array ( [id] => 5367144 [patent_doc_number] => 20090304703 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'Compositions and methods for the diagnosis and treatment of immune disorders' [patent_app_type] => utility [patent_app_number] => 12/284648 [patent_app_country] => US [patent_app_date] => 2008-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 61701 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0304/20090304703.pdf [firstpage_image] =>[orig_patent_app_number] => 12284648 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/284648
Compositions and methods for the diagnosis and treatment of immune disorders Sep 23, 2008 Issued
Array ( [id] => 7697142 [patent_doc_number] => 20110229448 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-22 [patent_title] => ' METHOD FOR IDENTIFYING ANTIGEN-SPECIFIC REGULATORY T CELLS' [patent_app_type] => utility [patent_app_number] => 12/678853 [patent_app_country] => US [patent_app_date] => 2008-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 17115 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20110229448.pdf [firstpage_image] =>[orig_patent_app_number] => 12678853 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/678853
Method for identifying antigen-specific regulatory T cells Sep 21, 2008 Issued
Array ( [id] => 6519434 [patent_doc_number] => 20100203068 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'METHODS OF SWITCHING THE PHENOTYPE OF T CELLS BY TRANSGENIC LINEAGE FACTOR FOXP3' [patent_app_type] => utility [patent_app_number] => 12/678724 [patent_app_country] => US [patent_app_date] => 2008-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 24471 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20100203068.pdf [firstpage_image] =>[orig_patent_app_number] => 12678724 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/678724
METHODS OF SWITCHING THE PHENOTYPE OF T CELLS BY TRANSGENIC LINEAGE FACTOR FOXP3 Sep 16, 2008 Abandoned
Array ( [id] => 6500444 [patent_doc_number] => 20100215674 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-26 [patent_title] => 'ENHANCING THE T-CELLS STIMULATORY CAPACITY OF HUMAN ANTIGEN PRESENTING CELLS AND THEIR USE IN VACCINATION' [patent_app_type] => utility [patent_app_number] => 12/677476 [patent_app_country] => US [patent_app_date] => 2008-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 17430 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20100215674.pdf [firstpage_image] =>[orig_patent_app_number] => 12677476 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/677476
Enhancing the T-cells stimulatory capacity of human antigen presenting cells and their use in vaccination Sep 11, 2008 Issued
Array ( [id] => 6440356 [patent_doc_number] => 20100279409 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-04 [patent_title] => 'METHOD FOR MODIFYING CELLUAR IMMUNE RESONSE BY MODULATING ACTIVIN ACTIVITY' [patent_app_type] => utility [patent_app_number] => 12/733670 [patent_app_country] => US [patent_app_date] => 2008-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7030 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0279/20100279409.pdf [firstpage_image] =>[orig_patent_app_number] => 12733670 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/733670
METHOD FOR MODIFYING CELLUAR IMMUNE RESONSE BY MODULATING ACTIVIN ACTIVITY Sep 10, 2008 Abandoned
Menu